Your browser doesn't support javascript.
loading
Evaluation of the Pharmacokinetic Interaction Between Letermovir and Tacrolimus in Allogeneic Hematopoietic Cell Transplantation Recipients.
Marciano, Kelsey A; Seago, Kelsea; Dillaman, Megan; Ross, Kelly G; Veltri, Lauren; Cumpston, Aaron.
Afiliación
  • Marciano KA; Department of Pharmacy, West Virginia University Medicine, Morgantown, West Virginia. Electronic address: kelsey.marciano@uchealth.org.
  • Seago K; Department of Pharmacy, West Virginia University Medicine, Morgantown, West Virginia; Osborn Hematopoietic Malignancy and Cellular Therapy Program, West Virginia University Cancer Institute, Morgantown, West Virginia.
  • Dillaman M; Department of Pharmacy, West Virginia University Medicine, Morgantown, West Virginia; Osborn Hematopoietic Malignancy and Cellular Therapy Program, West Virginia University Cancer Institute, Morgantown, West Virginia.
  • Ross KG; Osborn Hematopoietic Malignancy and Cellular Therapy Program, West Virginia University Cancer Institute, Morgantown, West Virginia.
  • Veltri L; Osborn Hematopoietic Malignancy and Cellular Therapy Program, West Virginia University Cancer Institute, Morgantown, West Virginia.
  • Cumpston A; Department of Pharmacy, West Virginia University Medicine, Morgantown, West Virginia; Osborn Hematopoietic Malignancy and Cellular Therapy Program, West Virginia University Cancer Institute, Morgantown, West Virginia.
Transplant Cell Ther ; 28(7): 371.e1-371.e4, 2022 07.
Article en En | MEDLINE | ID: mdl-35405369

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tacrolimus / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Transplant Cell Ther Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tacrolimus / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Transplant Cell Ther Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos